DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 153 filers reported holding DIPLOMAT PHARMACY INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $680,000 | -56.8% | 117,033 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $1,575,000 | -64.1% | 117,033 | -48.2% | 0.00% | -33.3% |
| Q3 2018 | $4,384,000 | +2.0% | 225,876 | +34.3% | 0.00% | -40.0% |
| Q2 2018 | $4,299,000 | -30.2% | 168,204 | -45.0% | 0.01% | -37.5% |
| Q1 2018 | $6,161,000 | +3.0% | 305,733 | +2.6% | 0.01% | 0.0% |
| Q4 2017 | $5,981,000 | -2.3% | 297,999 | +0.9% | 0.01% | 0.0% |
| Q3 2017 | $6,119,000 | +39.2% | 295,458 | -0.5% | 0.01% | +33.3% |
| Q2 2017 | $4,396,000 | -1.3% | 297,014 | +6.3% | 0.01% | 0.0% |
| Q1 2017 | $4,455,000 | +169.3% | 279,303 | +112.8% | 0.01% | +100.0% |
| Q4 2016 | $1,654,000 | -22.0% | 131,243 | +73.4% | 0.00% | -25.0% |
| Q3 2016 | $2,120,000 | -18.8% | 75,683 | +1.4% | 0.00% | -20.0% |
| Q2 2016 | $2,612,000 | +65.2% | 74,642 | +29.4% | 0.01% | +66.7% |
| Q1 2016 | $1,581,000 | -15.0% | 57,701 | +6.1% | 0.00% | 0.0% |
| Q4 2015 | $1,861,000 | -62.6% | 54,375 | -68.6% | 0.00% | -70.0% |
| Q3 2015 | $4,976,000 | -57.8% | 173,205 | -34.2% | 0.01% | -54.5% |
| Q2 2015 | $11,788,000 | +38.0% | 263,410 | +6.7% | 0.02% | +37.5% |
| Q1 2015 | $8,541,000 | +3.6% | 246,982 | -18.0% | 0.02% | 0.0% |
| Q4 2014 | $8,241,000 | – | 301,109 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|